Paul Singer’s activist fund has privately nominated a minority slate of director candidates for election to the board of the REIT, The Deal has learned, following a string of board changes announced by the company.
Leading companies are increasingly embracing female leadership in the C-Suite—with implications for more gender-balanced ranks at large, including on their companies’ boards.
To date, many organizations have focused on achieving gender balance across their boards and leadership teams with government support. Now, recent socio-political events are shining a powerful light on ethnic and racial diversity and for business to be representative of wider society. With the BoardEx Diversity Network, we are throwing our weight behind greater minority opportunity and better balance in business.
Why are some businesses so good at targeting the right buyer with the right offer via the right salesperson at the right time? The odds are they have centralized how they manage relationships – freeing up their sales teams from researching prospects to do what they do best: selling.
Tractors and Farm Equipment launched a campaign arguing that the Duluth, Ga.-based agricultural machinery manufacturer’s recently announced governance changes don’t go far enough.
Using some of their money to help others is in the DNA of many wealthy individuals and families. The next generation is already more committed to making a difference. This rising tide of philanthropy presents big opportunities for private banks and not-for-profits alike and they can realize them through the power of networks.
Sanjeev Gupta’s Liberty Steel gets access to Thyssenkrupp Steel’s books.
Is your business truly “data-driven”? If not, it should be. Using data analytics to generate insights for decision-making brings many benefits – including the ability to respond faster to changes in customers and the market. Start your journey to becoming a data-driven business with our three-stage roadmap.
The Anish Monga-led activist campaign puts a spotlight on possible M&A at the diagnostics and pharmaceuticals company.